Home | Business News | Browse by Publication | M | Medical Letter on the CDC & FDA

King Announces Commercial Availability of EMBEDA™.

Publication: Medical Letter on the CDC & FDA
Publication Date: 11-OCT-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
King Pharmaceuticals , Inc. (NYSE:KG) announced a true milestone as it marks the first commercial availability for EMBEDA™ (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. King has begun shipments of six dosage strengths (20 mg/0.8 mg, 30 mg/1.2 mg, 50 mg/2 mg, 60 mg/2.4 mg, 80 mg/3.2 mg and 100 mg/4 mg) and is...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Medical Letter on the CDC & FDA
Research from University of Cincinnati in the area of enzyme research ..., October 11, 2009
New hepatitis C virus research from University of Pennsylvania outline..., October 11, 2009
Protalix Reports Preclinical Data on Anti-TNF Follow-on Biologic Arthr..., October 11, 2009
Data from R.K. Mackenzie and colleagues advance knowledge in anesthesi..., October 11, 2009
New data from University of Guelph illuminate research in Escherichia ..., October 11, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.